Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-21

FDA Approved: SUCRALFATE — Original Application (Strides Pharma Science Limited)

View source ↗

Summary

The FDA approved Strides Pharma Science Limited's generic sucralfate under an Original Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUCRALFATE (SUCRALFATE)

Snippet

ORIG AP for SUCRALFATE (SUCRALFATE)